Page 45 - 林口長庚醫研部電子報-2018年6月刊
P. 45

NEWSLETTER  JUNE 2018  要做就要做到最好 - 頂尖暨優秀論文介紹  NEWSLETTER  JUNE 2018  要做就要做到最好 - 頂尖暨優秀論文介紹




 IF ≧ 5 或該領域前 10%                                                           IF ≧ 5 或該領域前 10%


 The survey of tinea capitis and scalp   Arachidonic Acid Induces ARE/Nrf2-Dependent
 dermatophyte carriage in nursing home   Heme Oxygenase-1 Transcription in Rat Brain

 residents                       Astrocytes
 MEDICAL MYCOLOGY, FEB. 2018     MOLECULAR NEUROBIOLOGY, APR. 2018
 IF= 2.377(5.88%)                IF= 6.19 (9.65%)

 第一作者:皮膚科林千又醫師                   第一作者:麻醉科林志中醫師
 指導作者:皮膚科孫培倫醫師





 Heterogeneity and irregularity of   Learning curve of image-guided video-assisted
 pretreatment F-18-fluorodeoxyglucose positron   thoracoscopic surgery for small pulmonary
 emission tomography improved prognostic   nodules: A prospective analysis of 30 initial
 stratification of p16-negative high-risk   patients

 squamous cell carcinoma of the oropharynx   JOURNAL OF THORACIC AND CARDIOVASCULAR
 ORAL ONCOLOGY, MAR. 2018        SURGERY, APR. 2018
 IF= 4.794 (1.11%)               IF= 4.446 (6.09%)

 指導作者:核子醫學科閻紫宸醫師                 第一作者:胸腔外科謝明儒醫師
                                 指導作者:胸腔外科趙盈凱醫師

 Radiosensitization of ultrasmall GNP-PEG-  Responses are durable for up to 5years after

 cRGDfK in ALTS1C1 exposed  to therapeutic   completion of peginterferon alfa-2a treatment
 protons and kilovoltage and megavoltage   in hepatitis B e antigen-positive patients
 photons                         ALIMENTARY  PHARMACOLOGY & THERAPEUTICS, MAY.
 INTERNATIONAL JOURNAL OF RADIATION  BIOLOGY,   2018

 MAR. 2018                       IF= 7.286(4.28%)
 IF= 1.992(9.09%)                指導作者:胃腸肝膽科系廖運範院士

 指導作者:放射腫瘤科洪志宏醫師



 In  Utero  Exposure  to  Exosomal  and  B-Cell   Comparison  of positron  emission  tomography/
 Alloantigens Lessens Alloreactivity of   computed  tomography  and  magnetic  resonance
 Recipients'  Lymphocytes  Rather  than Confers   im agin g fo r po stth erap y ev aluat ion

 Allograft Tolerance             in pa tients  with adv anced c ervical
 FRONTIERS IN IMMUNOLOGY, MAR. 2018  cancer receiving definitive concurrent
 IF= 6.429 (13.91%)              chemoradiotherapy

 第一 / 指導作者:小兒外科陳正昌醫師             EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND
                                 MOLECULAR IMAGING, MAY. 2018
                                 IF= 7.277 (2.38%)

                                 指導作者:核子醫學科劉豐源醫師






 43  非經本刊及作者同意,請勿做任何形式之轉載                                                                                          44
   40   41   42   43   44   45   46   47   48   49   50